Role of Interleukin-17A in Cell-mediated Protection Against Staphylococcus Aureus Infection in Mice Immunized with the Fibrinogen-binding Domain of Clumping Factor A

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2010 Aug 4

PMID 20679443

Citations 40

Authors

Kouji Narita

Dong-Liang Hu

Fumiaki Mori

Koichi Wakabayashi

Yoichiro Iwakura

Akio Nakane

Affiliations

Soon will be listed here.

Abstract

Clumping factor A (ClfA) is a fibrinogen-binding cell wall-attached protein and an important virulence factor of Staphylococcus aureus. Previous studies reported that an immunization with the fibrinogen-binding domain of ClfA (ClfA(40-559)) protected animals against S. aureus infection. It was reported that some cytokines are involved in the pathogenesis of staphylococcal diseases and in host defense against S. aureus infection. However, the role of cytokines in the protective effect of ClfA(40-559) as a vaccine has not been elucidated. In this study, we demonstrated that the spleen cells of ClfA(40-559)-immunized mice produced a large amount of interleukin-17A (IL-17A). The protective effect of immunization was exerted in wild-type mice but not in IL-17A-deficient mice. IL-17A mRNA expression was increased in the spleens and kidneys of immunized mice after infection. CXCL2 and CCL2 mRNA expression was increased in the spleens and kidneys, respectively. Consistent with upregulation of the mRNA expression, neutrophils infiltrated into the spleens extensively and macrophage infiltration was observed in the kidneys of immunized mice. These results suggest that immunization with ClfA(40-559) induces the IL-17A-producing cells and that IL-17-mediated cellular immunity is involved in the protective effect induced by immunization with ClfA(40-559) against S. aureus infection.

Citing Articles

Antimicrobial photodynamic therapy with Brazilian green propolis controls intradermal infection induced by methicillin-resistant Staphylococcus aureus and modulates the inflammatory response in a murine model.

Ribeiro I, Muniz I, Galantini M, Goncalves C, Lima P, Silva N Photochem Photobiol Sci. 2024; 23(3):561-573.

PMID: 38372844 DOI: 10.1007/s43630-024-00539-0.

Cross-Protection against Acute Lung Infection in Mice by a D-Glutamate Auxotrophic Vaccine Candidate.

Garcia P, Cabral M, Beceiro A, Moscoso M, Bou G Vaccines (Basel). 2023; 11(2).

PMID: 36851088 PMC: 9963018. DOI: 10.3390/vaccines11020210.

Progress towards the Elusive Mastitis Vaccines.

Rainard P, Gilbert F, Martins R, Germon P, Foucras G Vaccines (Basel). 2022; 10(2).

PMID: 35214754 PMC: 8876843. DOI: 10.3390/vaccines10020296.

T Cell Immunity and the Quest for Protective Vaccines against Infection.

Armentrout E, Liu G, Martins G Microorganisms. 2020; 8(12).

PMID: 33291260 PMC: 7762175. DOI: 10.3390/microorganisms8121936.

Targeting leukocidin-mediated immune evasion protects mice from Staphylococcus aureus bacteremia.

Tam K, Lacey K, Devlin J, Coffre M, Sommerfield A, Chan R J Exp Med. 2020; 217(9).

PMID: 32602902 PMC: 7478724. DOI: 10.1084/jem.20190541.

References

Molne L, Verdrengh M, Tarkowski A . Role of neutrophil leukocytes in cutaneous infection caused by Staphylococcus aureus. Infect Immun. 2000; 68(11):6162-7. PMC: 97694. DOI: 10.1128/IAI.68.11.6162-6167.2000. View

Reiner S . Development in motion: helper T cells at work. Cell. 2007; 129(1):33-6. DOI: 10.1016/j.cell.2007.03.019. View

Jaeschke H, Smith C . Mechanisms of neutrophil-induced parenchymal cell injury. J Leukoc Biol. 1997; 61(6):647-53. DOI: 10.1002/jlb.61.6.647. View

Qiu Z, Dillen C, Hu J, Verbeke H, Struyf S, Van Damme J . Interleukin-17 regulates chemokine and gelatinase B expression in fibroblasts to recruit both neutrophils and monocytes. Immunobiology. 2009; 214(9-10):835-42. DOI: 10.1016/j.imbio.2009.06.007. View

Nakane A, Nishikawa S, Sasaki S, Miura T, Asano M, KOHANAWA M . Endogenous interleukin-4, but not interleukin-10, is involved in suppression of host resistance against Listeria monocytogenes infection in interferon-depleted mice. Infect Immun. 1996; 64(4):1252-8. PMC: 173912. DOI: 10.1128/iai.64.4.1252-1258.1996. View

McLoughlin R, Lee J, Kasper D, Tzianabos A . IFN-gamma regulated chemokine production determines the outcome of Staphylococcus aureus infection. J Immunol. 2008; 181(2):1323-32. DOI: 10.4049/jimmunol.181.2.1323. View

Wu Q, Martin R, Rino J, Breed R, Torres R, Chu H . IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect. 2007; 9(1):78-86. PMC: 1832075. DOI: 10.1016/j.micinf.2006.10.012. View

Ouyang W, Kolls J, Zheng Y . The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity. 2008; 28(4):454-67. PMC: 3424508. DOI: 10.1016/j.immuni.2008.03.004. View

van Kooten C, Boonstra J, Paape M, Fossiez F, Banchereau J, Lebecque S . Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J Am Soc Nephrol. 1998; 9(8):1526-34. DOI: 10.1681/ASN.V981526. View

10.

Hobden J, Masinick S, Barrett R, Hazlett L . Proinflammatory cytokine deficiency and pathogenesis of Pseudomonas aeruginosa keratitis in aged mice. Infect Immun. 1997; 65(7):2754-8. PMC: 175388. DOI: 10.1128/iai.65.7.2754-2758.1997. View

11.

Bettelli E, Carrier Y, Gao W, Korn T, Strom T, Oukka M . Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441(7090):235-8. DOI: 10.1038/nature04753. View

12.

Hu D, Omoe K, Sasaki S, Sashinami H, Sakuraba H, Yokomizo Y . Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection. J Infect Dis. 2003; 188(5):743-52. DOI: 10.1086/377308. View

13.

Liu S, Tsai J, Shen C, Sher Y, Hsieh C, Yeh Y . Induction of a distinct CD8 Tnc17 subset by transforming growth factor-beta and interleukin-6. J Leukoc Biol. 2007; 82(2):354-60. DOI: 10.1189/jlb.0207111. View

14.

Jaeschke H . Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol. 2006; 290(6):G1083-8. DOI: 10.1152/ajpgi.00568.2005. View

15.

Ishigame H, Kakuta S, Nagai T, Kadoki M, Nambu A, Komiyama Y . Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity. 2009; 30(1):108-19. DOI: 10.1016/j.immuni.2008.11.009. View

16.

Park H, Li Z, Yang X, Chang S, Nurieva R, Wang Y . A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005; 6(11):1133-41. PMC: 1618871. DOI: 10.1038/ni1261. View

17.

Vaudaux P, Francois P, Proctor R, McDevitt D, Foster T, Albrecht R . Use of adhesion-defective mutants of Staphylococcus aureus to define the role of specific plasma proteins in promoting bacterial adhesion to canine arteriovenous shunts. Infect Immun. 1995; 63(2):585-90. PMC: 173036. DOI: 10.1128/iai.63.2.585-590.1995. View

18.

Vernachio J, Bayer A, Le T, Chai Y, Prater B, Schneider A . Anti-clumping factor A immunoglobulin reduces the duration of methicillin-resistant Staphylococcus aureus bacteremia in an experimental model of infective endocarditis. Antimicrob Agents Chemother. 2003; 47(11):3400-6. PMC: 253806. DOI: 10.1128/AAC.47.11.3400-3406.2003. View

19.

McDevitt D, Francois P, Vaudaux P, Foster T . Identification of the ligand-binding domain of the surface-located fibrinogen receptor (clumping factor) of Staphylococcus aureus. Mol Microbiol. 1995; 16(5):895-907. DOI: 10.1111/j.1365-2958.1995.tb02316.x. View

20.

Easmon C, GLYNN A . Cell-mediated immune responses in Staphylococcus aureus infections in mice. Immunology. 1975; 29(1):75-85. PMC: 1445861. View